Interactions between gadopentetate-dimeglumine(gadopentetate dimeglumine) and Iocetamic acid (iocetamic acid)
gadopentetate dimeglumine and iocetamic acid (Moderate Drug-Drug)
MANAGEMENT: Administration of any intravascular contrast agent should be deferred for 48 hours in patients with hepatic or biliary disorders who have recently received an oral cholecystographic contrast agent.






